China Medical gains Korean approval for anticancer HIFU (highintensity focused ultrasound) system:
This article was originally published in Clinica
The highintensity focused ultrasound (HIFU) tumour therapy system developed by Beijing-based China Medical Technologies has received official approval from the Korean FDA. The device is now approved to treat liver and pancreatic cancers and uterine fibroids. The firm received conditional approval to start US-based human trials of the device from the US FDA in July. Cancer is the leading cause of death in Korea.